Kinetic analysis on the sensitivity of glucose- or glyoxal-induced LDL glycation to the inhibitory effect of Psidium guajava extract in a physiomimic system

BioSystems

Volumn 88, Issue 1-2, 2007, Pages 92-100

  Hsieh, Chiu Lan ^a,b   Yang, Ming Hua ^a,b   Chyau, Charng Cherng ^a   Chiu, Chun Hon ^a   Wang, Hui Er ^b   Lin, Yuh Charn ^a   Chiu, Wen Ta ^c   Peng, Robert Y ^a  

^a Research Institute of Biotechnology   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Glucose; Glyoxal; Kinetic analysis; LDL glycation; Psidium guajava L.

Indexed keywords

GALLIC ACID; GLUCOSE; GLYOXAL; LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; PSIDIUM GUAJAVA EXTRACT; SCHIFF BASE; UNCLASSIFIED DRUG;

GLUCOSE; MEDICINAL PLANT; PHENOLIC COMPOUND; PLANT EXTRACT; REACTION KINETICS;

ARTICLE; AUTOOXIDATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; DRUG SENSITIVITY; GLYCATION; GUAVA; HUMAN; HYPERGLYCEMIA; KINETICS; MATHEMATICAL MODEL; NORMAL HUMAN;

PSIDIUM GUAJAVA;

EID: 33846885479     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biosystems.2006.04.004     Document Type: Article

References (29)

1. Agalou S., Karachalias N., Thornalley P.J., Tucker B., and Dawnay A.B. Estimation of α-oxoaldehydes formed from the degradation of glycolytic intermediates and glucose fragmentation in blood plasma of human subjects with uremia. Int. Congress Ser. 1245 (2002) 181-182
2. Aronson D., and Rayfield E.J. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc. Diabetol. 1 (2002) 1-10
3. Basta G., Schmidt A.M., and Acterina R.D. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res. 63 (2004) 582-592
4. Chalas J., Claise C., Edeas M., Messaoudi C., Vergnes L., Abella A., and Lindenbaum A. Effect of ethyl esterification of phenolic acids on low-density lipoprotein oxidation. Biomed. Pharmacother. 55 (2001) 54-60
5. Cheng R.T., and Yang Z.S. Hypoglycemic effect of Grava on the rabbits. Chin. Med. 31 (1983) 182-187
6. Duffy C.F., and Power R.F. Antioxidant and antimicrobial properties of some Chinese plant extracts. Int. J. Antimicrob. Agents 17 (2001) 527-529
7. Ezenwaka C.E., Akanji A.O., Osei K., Adejuwon C.A., O'Dorisio T.M., Cottrell D.A., and Akinlade K.S. Glucose and insulin response to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diab. Res. Clin. Pract. 20 (1993) 175-181
8. Harper H.A., Rodwell V.W., and Mayes P.A. Review of Physiological Chemistry. 16th ed. (1977), Lange Medical Publications, Los Altos, CA, USA pp. 584-585
9. Ichiki H., Miura T., Kubo M., Ishihara E., Komatsu Y., Tanigawa K., and Okada M. New antidiabetic compounds, mangiferin and its glucoside. Biol. Pharm. Bull. 21 (1998) m1389-m1390
10. Iwu M.M. Handbook of African Medicinal Plants (1993), CRC Press Inc., Boca Raton. 0-8493-4266-X pp. 223-322
11. Kerry N.L., and Abbey M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 135 (1997) 93-102
12. Kikuchi S., Shinpo K., Takeuchi M., Yamagishi S., Makita Z., Sasaki N., and Tashiro K. Glycation-a sweet tempter for neuronal death. Brain Res. Rev. 41 (2003) 306-323
13. Klein R.L., Laimins M., and Lopes-Virefla M.F. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type 1 diabetic patients and nondiabetic subjects. Diabetes 44 (1995) 1093-1098
14. Lee D., Park E.J., Cuendet M., Axelrod F., Chvez P.I., Fong H.H.S., Pezzuto J.M., and Kinghorn A.D. Cyclooxygenase-inhibitory and antioxidant constituents of aerial parts of Antirhea acutata. Bioorg. Med. Chem. 11 (2001) 1565-1568
15. Lee, S.H., 1986. Studies on active principles of hypoglycemic effect from Psidium grajava (II). Master Thesis. The Graduate Institute of Pharmacy, Taipei Medical College.
16. McCulloch D.K., Bingley P.J., Colman P., Jackson G.R., and Gale E.A.M. The ICARUS group. Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. Diab. Care 16 (1993) 911-915
17. Mosinger B.J. Copper-induced and photosensitive oxidation of low-density lipoprotein. The relation to cholesterol level and inter-species differences. Biochim. Biophys. Acta 1270 (1995) 73-80
18. Mullarkey C.J., Edelstein D., and Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173 (1990) 932-939
19. Munch G., Gerlach M., Sian J., Wong A., and Piederer P. Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress?. Ann. Neurol. Suppl. 1 (1996) s85-s88
20. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., and Shaw A. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267 (1992) 14998-15004
21. Pacini G., and Bergman R.N. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Programs Biomed. 23 (1986) 113-122
22. SAS. SAS User's Guide: Statistics (1985), SAS Institute, Inc., Cary, NC
23. Schwartz C.J., Valente A.J., Sprague E.A., et al. Pathogenesis of the atherosclerosis lesion. Implication for diabetes mellitus. Diab. Care 15 (1992) 1156-1167
24. Taga M.S., Miller E.E., and Pratt D.E. Chia seeds as a source of natural lipid antioxidants. Am. J. Oil Chem. Soc. 61 (1984) 928-931
25. Veassara H., and Palace M.R. Diabetes and glycation end-products. J. Intern. Med. 251 (2002) 87-101
26. Viana M., Barbas C., Bonet B., Bonet M.V., Castro M., Fraile M., and Herrera V.E. In vitro effects of a flavonoid-rich extract on LDL oxidation. Atherosclerosis 123 (1996) 83-91
27. Wautier J.L., Wautier M.P., Schmidt A.M., Anderson G.M., Hori O., Zoukourian C., Capron L., Chappey O., Yan S.D., and Brett J. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7742-7746
28. Yagi K. A simple fluorometric assay for lipid peroxides in blood serum or plasma. CRC Hand Book of Free Radicals and Antioxidants in Biomedicines vol. III (1989), CRC Press Inc., Boca Raton, FL p. 215
29. 2+-induced low density lipoprotein oxidation. FEBS Lett. 405 (1997) 186-190